Kesler Norman & Wride’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,910
Closed -$1.34M 247
2024
Q3
$1.34M Sell
9,910
-1,533
-13% -$205K 0.26% 87
2024
Q2
$1.55M Sell
11,443
-3,039
-21% -$413K 0.33% 78
2024
Q1
$1.87M Sell
14,482
-1,668
-10% -$202K 0.4% 80
2023
Q4
$1.85M Buy
16,150
+235
+1% +$23.5K 0.42% 69
2023
Q3
$1.45M Sell
15,915
-745
-4% -$76.8K 0.36% 84
2023
Q2
$1.88M Buy
16,660
+506
+3% +$53.5K 0.45% 70
2023
Q1
$1.69M Buy
16,154
+1,643
+11% +$172K 0.43% 77
2022
Q4
$1.6M Buy
14,511
+4,249
+41% +$445K 0.41% 80
2022
Q3
$897K Buy
10,262
+99
+1% +$9K 0.25% 97
2022
Q2
$795K Buy
10,163
+317
+3% +$26.2K 0.22% 109
2022
Q1
$839K Buy
9,846
+35
+0.4% +$3.35K 0.19% 110
2021
Q4
$1.18M Sell
9,811
-125
-1% -$15.5K 0.25% 90
2021
Q3
$1.23M Sell
9,936
-87
-0.9% -$11.2K 0.29% 83
2021
Q2
$1.26M Sell
10,023
-138
-1% -$15.8K 0.29% 86
2021
Q1
$1.07M Sell
10,161
-622
-6% -$63.1K 0.27% 91
2020
Q4
$1.1M Buy
+10,783
New +$1.01M 0.31% 86

Other funds holding XYL

Kesler Norman & Wride's XYL Position: Q4 2024 in Review

Kesler Norman & Wride sold out of Xylem (XYL) in Q4 2024, closing a stake of 9,910 shares — an estimated $1.34M sold.

Kesler Norman & Wride first reported a position in XYL in Q4 2020 and held it in 16 quarters. The position peaked at $1.88M in Q2 2023. 1,001 funds tracked by Wall St. Rank hold XYL as of Q4 2024.

  • Kesler Norman & Wride reported no remaining Xylem position as of Q4 2024 after selling out during the quarter.
  • Kesler Norman & Wride sold 9,910 Xylem shares in Q4 2024, an estimated $1.34M.
  • Kesler Norman & Wride first reported a position in Xylem in Q4 2020 and held it in 16 quarters.
  • Kesler Norman & Wride's Xylem position peaked at $1.88M in Q2 2023.
  • 1,001 funds tracked by Wall St. Rank held Xylem as of Q4 2024.

Based on Kesler Norman & Wride's 13F filing for Q4 2024, filed 12 Feb 2025.